Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Bellevue Life Sciences Acquisition Corp.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/27/2023 |
4
| Hwang Kuk Hyoun (CEO) has filed a Form 4 on Bellevue Life Sciences Acquisition Corp.
Txns:
| Acquired 20,000 shares
@ $0 Disposed of 20,000 options to buy
@ $11.5, valued at
$230k
|
|
03/27/2023 |
4
| Yoo David Jin (CFO) has filed a Form 4 on Bellevue Life Sciences Acquisition Corp.
Txns:
| Granted 20,000 shares
@ $0 Granted 20,000 options to buy
@ $11.5, valued at
$230k
|
|
03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/23/2023 |
4
| Hwang Kuk Hyoun (CEO) has filed a Form 4 on Bellevue Life Sciences Acquisition Corp.
Txns:
| Acquired 225,000 shares
@ $0 Disposed of 4,500 shares
@ $0 |
|
02/23/2023 |
4
| Bellevue Global Life Science Investors LLC (10% Owner) has filed a Form 4 on Bellevue Life Sciences Acquisition Corp.
Txns:
| Acquired 225,000 shares
@ $0 Disposed of 4,500 shares
@ $0 |
|
|
|